Light Therapy Device Tested Against Long COVID Brain Fog in Remote RCT
A double-blind trial tests whether 810nm photobiomodulation can reverse cognitive impairment in long COVID patients at home.
20 articles
A double-blind trial tests whether 810nm photobiomodulation can reverse cognitive impairment in long COVID patients at home.
Clinical trial explores how targeted light treatment could restore circadian rhythms and improve brain function in mild cognitive impairment.
A completed trial tests whether diode laser treatment reduces TLR-4 in saliva, linking periodontal inflammation to systemic aging biology.
A phase 1 trial tests RBD7022, a novel subcutaneous RNA-based therapy, for safety and dosing in adults with high LDL cholesterol.
Natural water therapy may offer safe relief from menopausal symptoms when hormone replacement isn't an option.
Researchers tracked immune changes during intensive radiation treatment to optimize cancer therapy and potential immunotherapy combinations.
Small study tested optical breast scanner to identify women at risk for hormone therapy-induced breast cancer within months of treatment.
A Phase 1/2 trial of NFS-02 gene therapy for LHON-associated vision loss was terminated before completion, raising questions about mitochondrial gene therapy.
Small trial tests psychedelic therapy combined with meditation for frontline healthcare providers suffering COVID-related burnout.
Study of 77 men reveals how androgen deficiency affects tear production and eye surface health, with potential treatment insights.
Small study tests whether tocilizumab can achieve faster, deeper remission in newly diagnosed rheumatoid arthritis patients.
Clinical trial tests whether testosterone replacement improves insulin resistance and heart health in men with diabetes and low testosterone.
Clinical trial investigated whether pressurized oxygen treatments could stimulate new blood vessel growth in elderly participants.
Three-year study of 363 men tests whether testosterone replacement therapy can reverse body composition changes and symptoms of aging.
60-person study tested psilocybin alone and with CBT for major depression, measuring brain activity and inflammatory markers.
A completed RCT tested whether a CBT-based smartphone app reduces moderate depression versus an active placebo in 158 participants; outcomes are not reported in the registration record.
UCSF study examines whether brief meditation intervention can improve biological markers of cellular stress and aging in both novice and experienced practitioners.
Researchers used retinal imaging to detect brain amyloid and tested whether telomerase activation could reduce Alzheimer's markers.
Small trial tests innovative immune cell therapy for patients with relapsed non-Hodgkin's lymphoma who failed standard treatments.
New study compares two regenerative therapies for knee osteoarthritis, offering alternatives to steroid injections.